ISIS 5132
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ISIS 5132, covering 2020-04-06 to 2020-04-06. Get the full timeline:
Most recent: Clinical Trial Update: ISIS 5132 in Treating Patients With Metastatic or Recurrent Ovarian Cancer [Phase 2]